Lower plasma protein C activity is associated with early myocardial necrosis and no-reflow phenomenon in patients with ST elevation myocardial infarction
- 11 September 2018
- journal article
- research article
- Published by Taylor & Francis in Acta Cardiologica
- Vol. 74 (4) , 331-339
Abstract
Background: Activity of protein C has important role in the development of early necrosis and no-reflow phenomenon in patients with ST-segment elevation myocardial infarction (STEMI) after successful primary percutaneous coronary intervention (pPCI). Methods: We examined association between plasma activity of protein C, antithrombin, coagulation factors II, VII, VIII and fibrinogen to early formation of new Q-waves (myocardial necrosis) before pPCI and early ST-segment resolution (microcirculatory reperfusion) after pPCI in patients with acute STEMI. According to ischaemic time, patients were considered as early or late presenters. 12-lead ECG was analysed for the presence of new Q-wave at admission and for significant ST-segment resolution 60 minutes after primary PCI. Results: In early presenters’ group, protein C activity was significantly lower in patients who did not achieve significant ST-segment resolution after pPCI compared to patients who did (1.11 IU/L vs. 0.99 IU/L, p = .006) and in patients who had new Q-waves compared to group who had not (1.04 UI/l vs. 1.11 IU/L, p = .038). There was significant negative correlation between protein C activity and maximal CK-MB levels (R2 = 0.06, p = .009) and BNP levels (R2 = 0.109, p = .003) and significant positive correlation between protein C activity with LVEF (R2 = 0.065, constant = 33.940, b = 11.968, p = .007) in early STEMI presenters. There were no differences between the activity of other examined haemostasis factors. Conclusion: Therefore we concluded that STEMI patients with early myocardial necrosis and no-reflow phenomenon after pPCI have lower activity of plasma protein C levels.Keywords
This publication has 31 references indexed in Scilit:
- Activated Protein C Has a Protective Effect against Myocardial I/R Injury by Improvement of Endothelial Function and Activation of AKT1PLOS ONE, 2012
- Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarctionCoronary Artery Disease, 2011
- Activated protein C protects against myocardial ischemic/reperfusion injury through AMP‐activated protein kinase signalingJournal of Thrombosis and Haemostasis, 2011
- The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implicationsBlood, 2010
- Predictive Factors and Impact of No Reflow After Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial InfarctionCirculation: Cardiovascular Interventions, 2010
- Clinical and Procedural Predictors of No-Reflow Phenomenon After Primary Percutaneous Coronary Interventions Experience at a Single CenterCirculation Journal, 2008
- No-reflow phenomenon and prognosis in patients with acute myocardial infarctionNature Clinical Practice Cardiovascular Medicine, 2006
- Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplastyAmerican Heart Journal, 2004
- Appearance of abnormal Q waves early in the course of acute myocardial infarction: Implications for efficacy of thrombolytic therapyJACC, 1995
- Biological risk factors for sudden death in patients with coronary artery disease and without heart failureInternational Journal of Cardiology, 1992